Shay Capital LLC Prelude Therapeutics Inc Transaction History
Shay Capital LLC
- $722 Million
- Q2 2025
A detailed history of Shay Capital LLC transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Shay Capital LLC holds 75,000 shares of PRLD stock, worth $63,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75,000Holding current value
$63,000% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PRLD
# of Institutions
50Shares Held
27.9MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$9.16 Million0.32% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$8.5 Million0.08% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$897,8890.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA933KShares$783,3580.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD928KShares$779,1900.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $30.6M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...